Yarlagadda Babu Latest Insider Activity
Management EfficiencyThe company has return on total asset (ROA) of (32.62) % which means that it has lost $32.62 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (224.59) % meaning that it created substantial loss on money invested by shareholders.
Entity SummaryBioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina. BioCryst Pharmaceuticals operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 85 people.BioCryst Pharmaceuticals (BCRX) is traded on BATS Exchange in USA. It is located in NORTH CAROLINA U.S.A and employs 85 people. BioCryst Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.
BioCryst Pharmaceuticals Leadership Team
Stock Performance Indicators